 Protalix BioTherapeutics Inc NYSE: PLX prices the previously announced underwritten public offering of 7.6 million shares at 4.60 per share, a discount of around 21 on the last close of 5.79 on Thursday. Underwriters have an option to purchase up to an additional 1.1 million shares. 